AAAAAA

   
Results: 1-15 |
Results: 15
Predicting mood disorders in breast cancer patients
Authors: Morasso, G Costantini, M Viterbori, P Bonci, F Del Mastro, L Musso, M Garrone, O Venturini, M
Citation: G. Morasso et al., Predicting mood disorders in breast cancer patients, EUR J CANC, 37(2), 2001, pp. 216-223
Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients
Authors: Venturini, M Michelotti, A Papaldo, P Del Mastro, L Bergaglio, M Lionetto, R Lunardi, G Sguotti, C Frevola, L Donati, S Rosso, R Cognetti, F
Citation: M. Venturini et al., Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients, ANN ONCOL, 12(8), 2001, pp. 1097-1106
Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients
Authors: Del Mastro, L Venturini, M Viscoli, C Bergaglio, M Signorini, A Bighin, C Bertell, G Semino, C Pietra, G Bertoglio, S Sertoli, MR Lambiase, A Rosso, R Melioli, G
Citation: L. Del Mastro et al., Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients, ANN ONCOL, 12(4), 2001, pp. 505-508
Impact of chemotherapy dose-density on radiotherapy dose-intensity after breast conserving surgery
Authors: Sanguineti, G Del Mastro, L Guenzi, M Ricci, P Cavallari, M Canavese, G Stevani, I Venturini, M
Citation: G. Sanguineti et al., Impact of chemotherapy dose-density on radiotherapy dose-intensity after breast conserving surgery, ANN ONCOL, 12(3), 2001, pp. 373-378
Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients. (vol 12, pg 1097, 2001)
Authors: Venturini, M Michelotti, A Papaldo, P Del Mastro, L Bergaglio, M Lionetto, R Lunardi, G Sguotti, C Frevola, L Donati, S Rosso, R Cognetti, F
Citation: M. Venturini et al., Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients. (vol 12, pg 1097, 2001), ANN ONCOL, 12(10), 2001, pp. 1498-1498
Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: Resultsof a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group
Authors: Del Mastro, L Venturini, M Lionetto, R Carnino, F Guarneri, D Gallo, L Contu, A Pronzato, P Vesentini, L Bergaglio, M Comis, S Rosso, R
Citation: L. Del Mastro et al., Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: Resultsof a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group, J CL ONCOL, 19(8), 2001, pp. 2213-2221
Does chemotherapy along with its dose-density adversely affect radiation induced acute toxicity after breast conserving surgery?
Authors: Guenzi, M Sanguineti, G Del Mastro, L Cavallari, M Ricci, P Bacigalupo, A Venturini, M
Citation: M. Guenzi et al., Does chemotherapy along with its dose-density adversely affect radiation induced acute toxicity after breast conserving surgery?, TUMORI, 87(4), 2001, pp. S42-S42
Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy
Authors: Pronzato, P Queirolo, P Vecchio, S Lionetto, R Del Mastro, L Venturini, M Gardin, G Alama, A Sertoli, MR
Citation: P. Pronzato et al., Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy, ONCOL-BASEL, 60(1), 2001, pp. 88-93
Sequence effect of epirubicin and paclitaxel treatment on pharmacokineticsand toxicity
Authors: Venturini, M Lunardi, G Del Mastro, L Vannozzi, MO Tolino, G Numico, G Viale, M Pastrone, I Angiolini, C Bertelli, G Straneo, M Rosso, R Esposito, M
Citation: M. Venturini et al., Sequence effect of epirubicin and paclitaxel treatment on pharmacokineticsand toxicity, J CL ONCOL, 18(10), 2000, pp. 2116-2125
Toremifene as a substitute for adjuvant tamoxifen in breast cancer patients
Authors: Bertelli, G Queirolo, P Vecchio, S Angiolini, C Bergaglio, M Del Mastro, L Signorini, A Valenzano, M Venturini, M
Citation: G. Bertelli et al., Toremifene as a substitute for adjuvant tamoxifen in breast cancer patients, ANTICANC R, 20(5C), 2000, pp. 3659-3661
Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients
Authors: Michelotti, A Venturini, M Tibaldi, C Bengala, C Gallo, L Carnino, F Del Mastro, L Lionetto, R Montanaro, E Rosso, R Conte, P
Citation: A. Michelotti et al., Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients, BREAST CANC, 59(2), 2000, pp. 133-139
Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale
Authors: Costantini, M Musso, M Viterbori, P Bonci, F Del Mastro, L Garrone, O Venturini, M Morasso, G
Citation: M. Costantini et al., Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale, SUPP CARE C, 7(3), 1999, pp. 121-127
Chemotherapy of non-small-cell lung cancer: Role of erythropoietin in the management of anemia
Authors: Del Mastro, L Gennari, A Donati, S
Citation: L. Del Mastro et al., Chemotherapy of non-small-cell lung cancer: Role of erythropoietin in the management of anemia, ANN ONCOL, 10, 1999, pp. 91-94
Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patients
Authors: Esposito, M Venturini, M Vannozzi, MO Tolino, G Lunardi, G Garrone, O Angiolini, C Viale, M Bergaglio, M Del Mastro, L Rosso, R
Citation: M. Esposito et al., Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patients, J CL ONCOL, 17(4), 1999, pp. 1132-1140
Treatment of breast cancer
Authors: Del Mastro, L Venturini, M
Citation: L. Del Mastro et M. Venturini, Treatment of breast cancer, N ENG J MED, 340(4), 1999, pp. 319-320
Risultati: 1-15 |